Authors:
Bewick, M
Conlon, M
Gerard, S
Lee, H
Parissenti, AM
Zhang, L
Gluck, S
Lafrenie, RM
Citation: M. Bewick et al., HER-2 expression is a prognostic factor in patients with metastatic breastcancer treated with a combination of high-dose cyclophosphamide, mitoxantrone, paclitaxel and autologous blood stem cell support, BONE MAR TR, 27(8), 2001, pp. 847-853
Authors:
Lightfoot, N
Conlon, M
Kreiger, N
Bissett, R
Desai, M
Warde, P
Prichard, HM
Citation: N. Lightfoot et al., Impact of noninvasive imaging on increased incidental detection of renal cell carcinoma, EUR UROL, 37(5), 2000, pp. 521-527
Authors:
Bewick, M
Chadderton, T
Conlon, M
Lafrenie, R
Morris, D
Stewart, D
Gluck, S
Citation: M. Bewick et al., Expression of C-erbB-2/HER-2 in patients with metastatic breast cancer undergoing high-dose chemotherapy and autologous blood stem cell support, BONE MAR TR, 24(4), 1999, pp. 377-384
Authors:
Behnke, M
Eyler, FD
Garvan, CW
Tenholder, MJ
Wobie, K
Woods, NS
Conlon, M
Cumming, W
Citation: M. Behnke et al., Cranial ultrasound abnormalities identified at birth: Their relationship to perinatal risk and neurobehavioral outcome, PEDIATRICS, 103(4), 1999, pp. E411-E416